A population analysis of the pharmacokinetics of Cremophor EL using nonlinear mixed-effect modelling

被引：0
|
作者：
H. van den Bongard
R. Mathôt
O. van Tellingen
J. Schellens
J. Beijnen
机构：
[1] Department of Pharmacy and Pharmacology,
[2] Slotervaart Hospital/The Netherlands Cancer Institute,undefined
[3] Louwesweg 6,undefined
[4] 1066 EC Amsterdam,undefined
[5] The Netherlands,undefined
[6] Department of Clinical Chemistry Laboratory,undefined
[7] Antoni van Leeuwenhoek Hospital/The Netherlands Cancer Institute,undefined
[8] Amsterdam,undefined
[9] The Netherlands,undefined
[10] Department of Medical Oncology,undefined
[11] Antoni van Leeuwenhoek Hospital/The Netherlands Cancer Institute,undefined
[12] Amsterdam,undefined
[13] The Netherlands,undefined
[14] Division of Drug Toxicology,undefined
[15] Department of Biomedical Analysis,undefined
[16] Faculty of Pharmacy,undefined
[17] Utrecht University,undefined
[18] Utrecht,undefined
[19] The Netherlands,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2002年 / 50卷
关键词：
Cremophor EL Population pharmacokinetic model Validation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Abstract
引用
收藏
页码：16 / 24
页数：8
相关论文
共 50 条
  • [21] Determination of population pharmacokinetic parameters for amikacin in neonates using mixed-effect models
    Botha, JH
    du Preez, M
    Miller, R
    Adhikari, M
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 53 (05) : 337 - 341
  • [22] Determination of population pharmacokinetic parameters for amikacin in neonates using mixed-effect models
    J. H. Botha
    M. J. du Preez
    R. Miller
    M. Adhikari
    [J]. European Journal of Clinical Pharmacology, 1998, 53 : 337 - 341
  • [23] Population pharmacokinetics of orally administered paclitaxel formulated in cremophor EL co-administered with cyclosporin A
    de Jonge, ME
    Huitema, ADR
    Schellens, JHM
    Rodenhuis, S
    Beijnen, JH
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (05) : 610 - 610
  • [24] A Nonlinear Mixed Effects Modelling Analysis of Topiramate Pharmacokinetics in Patients with Epilepsy
    Vovk, Tomaz
    Jakovljevic, Mihajlo B.
    Kos, Mojca Kerec
    Jankovic, Slobodan M.
    Mrhar, Ales
    Grabnar, Iztok
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2010, 33 (07) : 1176 - 1182
  • [25] Increased sensitivity in fMRI group analysis using mixed-effect modeling
    Keller, Merlin
    Roche, Alexis
    [J]. 2008 IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: FROM NANO TO MACRO, VOLS 1-4, 2008, : 548 - +
  • [26] Quantifying individual variation in behaviour: mixed-effect modelling approaches
    Dingemanse, Niels J.
    Dochtermann, Ned A.
    [J]. JOURNAL OF ANIMAL ECOLOGY, 2013, 82 (01) : 39 - 54
  • [27] Mixed-Effect Modeling of Ethanol Pharmacokinetics in Korean Healthy Male Subjects
    Han, Seunghoon
    Hong, Taegon
    Park, Gab-Jin
    Youn, Sunil
    Park, Wan-Su
    Kim, Daejin
    Yim, Dong-Seok
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 : S78 - S78
  • [28] PHARMACOKINETICS OF THE DIGOXIN-QUINIDINE INTERACTION VIA MIXED-EFFECT MODELING
    WILLIAMS, PJ
    LANE, J
    MURRAY, W
    MERGENER, MA
    KAMIGAKI, M
    [J]. CLINICAL PHARMACOKINETICS, 1992, 22 (01) : 66 - 74
  • [29] Gender differences in pharmacokinetics of perfluoropentanoic acid using non-linear mixed-effect modeling in rats
    Choi, Go-Wun
    Choi, Eun-Jeong
    Kim, Ju Hee
    Kang, Dong Wook
    Lee, Yong-Bok
    Cho, Hea-Young
    [J]. ARCHIVES OF TOXICOLOGY, 2020, 94 (05) : 1601 - 1612
  • [30] Pharmacokinetics and Pharmacodynamics of Meropenem in Elderly Chinese with Lower Respiratory Tract Infections Population Pharmacokinetics Analysis Using Nonlinear Mixed-Effects Modelling and Clinical Pharmacodynamics Study
    Zhou, Qing-tao
    He, Bei
    Zhang, Chao
    Zhai, Suo-di
    Liu, Zhen-ying
    Zhang, Jie
    [J]. DRUGS & AGING, 2011, 28 (11) : 903 - 912
12345